Good Life Advisors LLC Trims Position in MetLife, Inc. (NYSE:MET)

Good Life Advisors LLC lowered its stake in shares of MetLife, Inc. (NYSE:METFree Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 5,022 shares of the financial services provider’s stock after selling 1,156 shares during the period. Good Life Advisors LLC’s holdings in MetLife were worth $411,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in MET. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in MetLife by 1.5% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after acquiring an additional 68,579 shares during the period. Nordea Investment Management AB raised its stake in shares of MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after purchasing an additional 608,224 shares during the last quarter. Swedbank AB lifted its holdings in shares of MetLife by 76.0% during the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after purchasing an additional 1,496,645 shares during the period. Jennison Associates LLC grew its position in MetLife by 3.6% in the 4th quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock valued at $268,096,000 after buying an additional 114,166 shares during the last quarter. Finally, Stifel Financial Corp increased its stake in MetLife by 5.0% in the 3rd quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after buying an additional 105,762 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Down 0.3 %

MET opened at $82.82 on Friday. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05. The company has a market cap of $57.34 billion, a price-to-earnings ratio of 13.87, a PEG ratio of 0.65 and a beta of 1.07. The business’s fifty day moving average is $83.45 and its two-hundred day moving average is $81.26. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.63%. MetLife’s dividend payout ratio is presently 36.52%.

Wall Street Analyst Weigh In

Several analysts have recently commented on MET shares. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Wells Fargo & Company raised their price objective on shares of MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research report on Wednesday. Keefe, Bruyette & Woods dropped their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 12th. BMO Capital Markets started coverage on MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target for the company. Finally, TD Cowen lifted their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $92.58.

Read Our Latest Stock Report on MetLife

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.